A detailed history of Personal Cfo Solutions, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 2,984 shares of EXAS stock, worth $173,400. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,984
Holding current value
$173,400
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $126,611 - $211,356
2,984 New
2,984 $203,000
Q1 2024

May 13, 2024

SELL
$56.27 - $73.77 $8,496 - $11,139
-151 Reduced 4.79%
3,004 $207,000
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $186,334 - $238,896
3,155 New
3,155 $233,000
Q2 2023

Aug 10, 2023

BUY
$62.68 - $95.05 $151,121 - $229,165
2,411 New
2,411 $226,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.